Chile’s economic overseer, the FNE, was presented this week with expert testimony from Yale economist James Levinsohn, during ongoing proceedings into determining whether three major Drug store chains entered into illegal agreements to raise the price of their products.
The FNE has accused 10 executives from the Salcobrand, Cruz Verde and Farmacias Ahumada chains of having established this agreement. The FNE asserts that Salcobrand executives would have led the rise in prices in coordination with their rivals, offering to take the first step in raising its own prices in order for their competitors to emulate them in predetermined intervals.
The Yale economist, who was called as a witness for the Defense, agreed in theory with the FNE’s interpretation that there doesn’t need to be any written agreement to coordinate such a price-fixing scheme, and therefore a written document is not needed for such actions to represent an ‘implicit’ collusion. According to the FNE, such unwritten coordination would have been facilitated by several Laboratories, who would act as messengers between the drugstore chains.
Full content: T13
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Hess Shareholders Approve $53 Billion Merger with Chevron
May 28, 2024 by
CPI
EU Regulators Engage with Telegram as App Nears Critical Usage Threshold
May 28, 2024 by
CPI
EEX Offers Remedies to Address EU Antitrust Concerns Over Nasdaq Deal
May 28, 2024 by
CPI
BRG Expands European Competition Practice with New Expert Team in Brussels
May 28, 2024 by
CPI
UK Law Empowers Regulators to Fine Big Tech Without Court Approval
May 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI